» Authors » Anna Marco-Ramell

Anna Marco-Ramell

Explore the profile of Anna Marco-Ramell including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 212
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Palau-Rodriguez M, Marco-Ramell A, Casas-Agustench P, Tulipani S, Minarro A, Sanchez-Pla A, et al.
J Proteome Res . 2021 Mar; 20(5):2410-2419. PMID: 33760621
Alterations in visceral adipose tissue (VAT) are closely linked to cardiometabolic abnormalities. The aim of this work is to define a metabolic signature in VAT of insulin resistance (IR) dependent...
2.
Marco-Ramell A, Tulipani S, Palau-Rodriguez M, Gonzalez-Dominguez R, Minarro A, Jauregui O, et al.
J Proteome Res . 2018 Jun; 17(7):2307-2317. PMID: 29905079
This study explores the metabolic profiles of concordant/discordant phenotypes of high insulin resistance (IR) and obesity. Through untargeted metabolomics (LC-ESI-QTOF-MS), we analyzed the fasting serum of subjects with high IR...
3.
Palau-Rodriguez M, Tulipani S, Marco-Ramell A, Minarro A, Jauregui O, Gonzalez-Dominguez R, et al.
J Proteome Res . 2018 Jun; 17(8):2704-2714. PMID: 29893570
The exact impact of bariatric surgery in metabolically "healthy" (MH) or "unhealthy" (MU) phenotypes for the study of the metabolic improvement is still unknown. We applied an untargeted LC-ESI-TripleTOF-MS-driven metabolomics...
4.
Palau-Rodriguez M, Tulipani S, Marco-Ramell A, Minarro A, Jauregui O, Sanchez-Pla A, et al.
PLoS One . 2018 Jun; 13(6):e0198214. PMID: 29856816
Objective: Bariatric surgery is considered the most efficient treatment for morbid obesity and its related diseases. However, its role as a metabolic modifier is not well understood. We aimed to...
5.
Marco-Ramell A, Palau-Rodriguez M, Alay A, Tulipani S, Urpi-Sarda M, Sanchez-Pla A, et al.
BMC Bioinformatics . 2018 Jan; 19(1):1. PMID: 29291722
Background: Bioinformatic tools for the enrichment of 'omics' datasets facilitate interpretation and understanding of data. To date few are suitable for metabolomics datasets. The main objective of this work is...
6.
Gillespie A, Pan X, Marco-Ramell A, Meharg C, Green B
Peptides . 2017 Sep; 96:20-30. PMID: 28870797
STC-1 is a heterogeneous plurihormonal cell line producing several prominent gut peptide hormones. pGIP/Neo is a genetically selected sub-clone of STC-1 with augmented levels of glucose-dependent insulinotropic peptide (GIP). Morphometric...
7.
Marco-Ramell A, Arroyo L, Pena R, Pato R, Saco Y, Fraile L, et al.
BMC Vet Res . 2016 Nov; 12(1):265. PMID: 27887661
Background: The objective assessment of animal stress and welfare requires proper laboratory biomarkers. In this work, we have analyzed the changes in serum composition in gilts after switching their housing,...
8.
Tulipani S, Palau-Rodriguez M, Minarro Alonso A, Cardona F, Marco-Ramell A, Zonja B, et al.
Clin Chim Acta . 2016 Nov; 463:53-61. PMID: 27720726
Metabolomic studies aimed to dissect the connection between the development of type 2 diabetes and obesity are still scarce. In the present study, fasting serum from sixty-four adult individuals classified...
9.
Marco-Ramell A, Hummel K, Razzazi-Fazeli E, Bassols A, Miller I
Electrophoresis . 2014 Nov; 36(4):543-51. PMID: 25377528
Apolipoprotein A-I (Apo A-I) is a major protein in lipid/lipoprotein metabolism and decreased serum levels have been observed in many species in response to inflammatory and infectious challenges. Little is...
10.
Marco-Ramell A, Miller I, Nobauer K, Moginger U, Segales J, Razzazi-Fazeli E, et al.
J Proteomics . 2014 Mar; 101:205-16. PMID: 24576640
Biological Significance: PCV2-SD is a disease of great economic importance for pig production, characterized by a complex response of the immune system. In the search of a better diagnostic/prognostic marker...